Blog
RSS FeedPosted by Michael Wonder on 04 Dec 2016
GSK’s Anne Belcher says certainty on government policy is crucial
5 December 2016 - British pharmaceutical giant GSK’s Australia head, Anne Belcher, has called for long-term consistent government policy as ...
Posted by Michael Wonder on 03 Dec 2016
CADTH publishes final outcome for Afinitor (everolimus)
1 December 2016 - The outcome relates to the use of everolimus for the treatment of patients with a neuroendocrine ...
Posted by Michael Wonder on 02 Dec 2016
CADTH publishes final outcome for Darzalex (daratumumab)
1 December 2016 - The outcome relates to the use of daratumumab for the treatment of patients with multiple myeloma. ...
Posted by Michael Wonder on 02 Dec 2016
NICE recommends new lung cancer drug pembrolizumab
2 December 2016 - Hundreds of people with advanced lung cancer will now have access to new drug pembrolizumab, also known ...
Posted by Michael Wonder on 02 Dec 2016
Review of pharmacy remuneration and regulation - pharmacy financial survey
2 December 2016 - In his December Message from the Chair, Prof Stephen King extends an invitation to all Australian ...
Posted by Michael Wonder on 01 Dec 2016
Agenda for 7 December 2016 TC meeting
2 December 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 01 Dec 2016
CADTH publishes initial recommendation for Venclexta (venetoclax)
1 December 2016 - The outcome relates to the use of venetoclax for the treatment of patients with chronic lymphocytic ...
Posted by Michael Wonder on 01 Dec 2016
My mother bought me PrEP for Christmas: How far we've come in the fight against AIDS
1 December 2016 - When we look back on the history of HIV and the AIDS crisis on World AIDS ...
Posted by Michael Wonder on 01 Dec 2016
PrEP: Advocates call for greater affordability and access to new preventative HIV method
1 December 2016 - A new AIDS prevention method known as PrEP is the most effective tool yet to reduce ...
Posted by Michael Wonder on 01 Dec 2016
GSK gets green light to sell breakthrough asthma treatment to the NHS
1 December 2016 - GlaxoSmithKline has had one of its most promising new asthma drugs recommended for use on the ...
Posted by Michael Wonder on 30 Nov 2016
Patients gain subsidised access to expensive new medicines
1 December 2016 - Australians from 1 December will pay no more than $38.30 for a medicine to treat thyroid cancer ...
Posted by Michael Wonder on 30 Nov 2016
Schedule of Pharmaceutical Benefits - 1 December 2016 update
1 December 2016 - The 1 December 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 30 Nov 2016
Expensive thyroid cancer drug now $38
30 November 2016 - Thyroid cancer patients spending more than $100,000 a year on treatment will be able to access ...
Posted by Michael Wonder on 30 Nov 2016
87 per cent of Aussies believe private health insurance is expensive
30 November 2016 - Over 5 million Aussies reviewed their policy in the last 12 months. ...
Posted by Michael Wonder on 30 Nov 2016
In the real world
30 November 2016 - The type of evidence NICE uses to make decisions is a hotly contested topic — and rightly ...